Bendell, Johanna C <br/><br/>
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer.  [electronic resource] 

 -  Cancer investigation  Jul 2017 
 - 386-392 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1532-4192 
<br/><br/><label>Standard No.: </label>10.1080/07357907.2017.1310221  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Axitinib<br/>Bevacizumab--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Indazoles--administration & dosage<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--administration & dosage<br/>Treatment Outcome